Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shipi Xiaoshui Gao is a Traditional Chinese Medicine (TCM) topical paste primarily utilized for the management of malignant ascites and refractory edema in patients with advanced cancers, such as hepatocellular carcinoma or gastric cancer. The formulation is based on the classical 'Shipi Yin' decoction and is designed to be applied externally to the Shenque (umbilicus) acupuncture point. Its therapeutic mechanism involves warming the kidney and strengthening the spleen to promote the transformation and excretion of dampness, thereby facilitating the resorption of peritoneal fluid. Clinical research in China suggests that it acts as an effective adjuvant therapy to conventional treatments like abdominal paracentesis and diuretics, helping to reduce the rate of fluid accumulation and improve the quality of life for terminal cancer patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shipi xiaoshui gao.